Pronađeno: 1-7 / 7 radova

Autori: Petzer Andreas L

>> Filter: Samo Article i Review

Naslov High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients - final analysis of a randomized, multicenter, phase III trial (Article)
Autori Petzer Andreas L  ...  Bogdanovic Andrija D  ...  (broj koautora 20) 
Info HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, (2012), vol. 97 br. 10, str. 1562-1569
Projekat Novartis
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Pre-treated CML Patients in chronic phase (CP) not achieving at least a major cytogenetic remission (MCyR) after imatinib high dose (HD) induction (800 mg/day, 6 months) are at high risk of progression after dose reduction - Sub-analyses from the CELSG phase III "ISTAHIT" trial (Meeting Abstract)
Autori Petzer Andreas L  Fong Dominic  Lion Thomas  Dyagil Irina  Masliak Zvenyslava  Bogdanovic Andrija D  Griskevicius Laimonas  Lejniece Sandra  Goranov Stefan  Gercheva Liana  Stojanovic Aleksandar  Peytchev Dontcho  Tzvetkov Nikolay  Griniute Rasa  Oucheva Radka  Grubinger T  Kwakkelstein Marthin  Rancati Francesca  Gastl Guenther A  Wolf Dominik 
Info ONKOLOGIE, (2011), vol. 34 br. , Suppl. 6, str. 264-264
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Significantly higher and more rapid cytogenetic and molecular responses can be achieved in pre-treated chronic phase CML patients with high doses of Imatinib as induction therapy (800 mg/day, 6 months) - final results of a Phase III CELSG CML11 "ISTAHIT" TRIAL (Meeting Abstract)
Autori Petzer Andreas L  ...  Bogdanovic Andrija D  ...  (broj koautora 20) 
Info ONKOLOGIE, (2010), vol. 33 br. , Suppl. Suppl. 6, str. 83-83
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov High Dose Imatinib Induction (800 Mg/day, 6 Months) Induces Significantly Higher Cytogenetic and Molecular Responses in Pre-treated Chronic Phase CML -phase III Celsg 'istahit' Trial - First Results (Meeting Abstract)
Autori Petzer Andreas L  ...  Bogdanovic Andrija D  ...  Stojanovic Aleksandar  ...  (broj koautora 20) 
Info HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, (2010), vol. 95 br. , Suppl. Suppl. 2, str. 0133-
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study (Article)
Autori Petzer Andreas L  Wolf Dominik  Fong Dominic  Lion Thomas  Dyagil Irina  Masliak Zvenyslava  Bogdanovic Andrija D  Griskevicius Laimonas  Lejniece Sandra  Goranov Stefan  Gercheva Liana  Stojanovic Aleksandar  Peytchev Dontcho  Tzvetkov Nikolay  Griniute Rasa  Oucheva Radka  Ulmer Hanno  Kwakkelstein Marthin  Rancati Francesca  Gastl Guenther A 
Info HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, (2010), vol. 95 br. 6, str. 908-913
Projekat Novartis
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Celsg Cml 11 "Istahit" Phase Iii Study - Planned Interim Analysis: High Doses Of Imatinib Mesylate (800mg/Day) Significantly Improve Rates Of Major And Complete Cytogenetic Remissions (Mcr, Ccr) In Pretreated Ph+/Bcr-Abl(+) Cml Patients In Chronic Phase (Meeting Abstract)
Autori Petzer Andreas L  Boskovic Darinka V  Gastl Guenther A 
Info BLOOD, (2008), vol. 112 br. 11, str. 406-406
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Multicenter, randomized, phase III study comparing imatinib (Glivec) standard dose (400 mg/d) with imatinib high dose induction (800 mg/d) followed by imatinib maintenance (400 mg/d) in patients with pretreated Ph+/BCR-ABL(+) CML in chronic phase - Results from the first planned interim analysis (CELSG-CML 11 ISTAHIT study) (Meeting Abstract)
Autori Petzer Andreas L  Wolf Dominik  Fong Dominic  Lion Thomas  Dyagil Irina  Masliak Zvenyslava  Boskovic Darinka V  Griskevicius Laimonas  Lejniece Sandra  Spasov Emil  Gercheva Liana  Stojanovic Aleksandar  Peytchev Dontcho  Tzvetkov Nikolay  Griniute Rasa  Stanchev Atanas  Kwakkelstein Martin  Ulmer Hanno  Gastl Guenther A 
Info BLOOD, (2007), vol. 110 br. 11, str. 317A-317A
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX